Bcel stock forecast.

Stock Price Forecast The 31 analysts offering 12-month price forecasts for Li Auto Inc have a median target of 51.71, with a high estimate of 79.79 and a low estimate of 35.71.Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Keurig Dr Pepper Inc have a median target of 37.00, with a high estimate of 42.00 and a low estimate of 27.00. The ...DUK Stock 12 Months Forecast. $97.00. (4.71% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Duke Energy in the last 3 months. The average price target is $97.00 with a high forecast of $103.00 and a low forecast of $89.00. The average price target represents a 4.71% change from the last price of $92.64.2010. 90. John Orwin. https://www.atreca.com. Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified ...Dec 1, 2023 · Their VKTX share price targets range from $19.00 to $37.00. On average, they predict the company's stock price to reach $30.25 in the next twelve months. This suggests a possible upside of 132.5% from the stock's current price. View analysts price targets for VKTX or view top-rated stocks among Wall Street analysts.

Forecst.com predicts future values using technical analysis of a large number of analytical parameters. BCEL stock returns are also predicted based on historical data. According to our research, BCEL stock is a bad long-term investment. BCEL share price has been in a bear cycle for the past year. Atreca, Inc. stock trend is negative .The BCEL shares have gain 66.93% over the last week, with a monthly amount glided 11.79%, and seem to be holding At the time of writing, Atreca Inc [BCEL] stock is trading at $0.38, up 61.06%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value.

The Cymabay Therapeutics Inc stock price gained 1.86% on the last trading day (Thursday, 30th Nov 2023), rising from $18.78 to $19.13. During the last trading day the stock fluctuated 4.76% from a day low at $18.89 to a day high of $19.79. The price has risen in 6 of the last 10 days and is up by 6.28% over the past 2 weeks.View SilverBow Resources SBOW investment & stock information. Get the latest SilverBow Resources SBOW detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

The Cymabay Therapeutics Inc stock price gained 6.70% on the last trading day (Friday, 24th Nov 2023), rising from $17.90 to $19.10. During the last trading day the stock fluctuated 6.58% from a day low at $17.92 to a day high of $19.10. The price has risen in 8 of the last 10 days and is up by 28.53% over the past 2 weeks.4/13 ratings generated profit. 31%. Average Return. -37.24%. reiterated a buy rating 10 months ago. Copying Do Kim 's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of -37.24% per trade. 2 Years. dummy dummy.Fiscal Q3 2023 ended 9/30/23. Get the latest Atreca Inc (BCEL) real-time quote, historical performance, charts, and other financial information to help you make more informed …If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...

Cenovus Energy Inc () Stock Market info Recommendations: Buy or sell Cenovus Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cenovus Energy share forecasts, stock quote and buy / sell signals below.According to present data Cenovus Energy's CVE shares and potentially its market environment have …

12 analysts have issued twelve-month price objectives for CymaBay Therapeutics' stock. Their CBAY share price targets range from $12.00 to $34.00. On average, they anticipate the company's stock price to reach $22.27 in the next year. This suggests a possible upside of 24.4% from the stock's current price. View analysts price targets for CBAY ...

The current Atreca [ BCEL] share price is $0.21. The Score for BCEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. BCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels. Read Full Company Summary for BCEL here. View Atreca, Inc BCEL investment & stock information. Get the latest Atreca, Inc BCEL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.FIXX Stock 12 Months Forecast. Based on 1 Wall Street analysts offering 12 month price targets for Homology Medicines in the last 3 months. The average price target is $1.50 with a high forecast of $1.50 and a low forecast of $1.50. The average price target represents a 167.81% change from the last price of $0.56.Nov 29, 2023 · Qifu Technology (NASDAQ:QFIN) pays an annual dividend of $0.98 per share and currently has a dividend yield of 6.10%. QFIN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 28.16%. This payout ratio is at a healthy, sustainable level, below 75%. Price target. 1.93D CAD +1.58 +451.02%. The 7 analysts offering 1 year price forecasts for ENTHUSIAST GAMING HOLDINGS INC have a max estimate of 2.50 and a min estimate of 1.50. Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...The current Atreca [ BCEL] share price is $0.21. The Score for BCEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. BCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Atreca Inc. Cl A analyst ratings, historical stock prices, earnings estimates & actuals. BCEL updated stock price target summary. Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Science. Atreca Inc (NASDAQ:BCEL)’s traded shares stood at 0.33 million during the last session, with the company’s beta value hitting 1.24. At the close of trading, the stock’s price was $0.21. The BCEL share’s 52-week high remains $2.05, putting it -876.19% down since that peak but still an impressive 9.52% since price per share fell ...See ENTHUSIAST GAMING HOLDINGS INC stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Forecast . Price target. 1.93 0.00 0.00%. The 7 analysts offering 1 year price forecasts for EGLX have a max estimate of — and a min estimate of —.A treca, Inc. (BCEL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Stock Trend Capital share forecasts, stock quote and buy / sell signals below. According to present data Stock Trend Capital's PUMP shares and potentially its market environment have been in bearish cycle last 12 months (if exists).A list of analyst ratings for Atreca (BCEL) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. ... Forecast; Analyst Ratings; BCEL's stock price has decreased by -82.11% in the past year and price targets may not have had time to catch up.

Next reporting date. December 19, 2023. EPS forecast (this quarter) -$0.08. Annual revenue (last year) $130.5M. Annual profit (last year) -$142.7M. Net profit margin.HOOK Stock 12 Months Forecast. $6.83. (1382.20% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Hookipa Pharma in the last 3 months. The average price target is $6.83 with a high forecast of $7.00 and a low forecast of $6.50. The average price target represents a 1382.20% change from the last price of $0.46.The Cymabay Therapeutics Inc stock price gained 6.70% on the last trading day (Friday, 24th Nov 2023), rising from $17.90 to $19.10. During the last trading day the stock fluctuated 6.58% from a day low at $17.92 to a day high of $19.10. The price has risen in 8 of the last 10 days and is up by 28.53% over the past 2 weeks.Turning Spencer's outlook into concrete recommendations, Baird analyst Joel Beatty is pounding the table on two stocks that look especially compelling. According to the analyst, each name is ...Next reporting date. December 19, 2023. EPS forecast (this quarter) -$0.08. Annual revenue (last year) $130.5M. Annual profit (last year) -$142.7M. Net profit margin.231.40. -1.20%. 108.31K. Find the latest Atreca Inc (BCEL) stock forecast, 12-month price target, predictions and analyst recommendations.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Century Aluminum share forecasts, stock quote and buy / sell signals below. According to present data Century Aluminum's CENX shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). April 06, 2023 — 09:55 am EDT. Written by Zacks Equity Research for Zacks ->. Shares of Atreca, Inc. (BCEL) have been struggling lately and have lost 20% over the past week. However, a hammer ...The current Cheniere Energy [ LNG] share price is $179.21. The Score for LNG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. LNG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

The average Morphic Holding stock price prediction forecasts a potential upside of 124.84% from the current MORF share price of $23.72. What is MORF's forecast return on equity (ROE) for 2023-2025? (NASDAQ: MORF) forecast ROE is -29.51%, which is considered weak.

Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now Zacks - Thu Apr 6, 8:55AM CDT . Atreca, Inc. (BCEL) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall...

Price target. 1.93D CAD +1.58 +451.02%. The 7 analysts offering 1 year price forecasts for ENTHUSIAST GAMING HOLDINGS INC have a max estimate of 2.50 and a min estimate of 1.50. Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.Atreca Inc (BCEL) Stock Price & News - Google Finance Home BCEL • NASDAQ Atreca Inc Follow Share $0.21 After Hours: $0.22 (2.90%) +0.0062 Closed: Nov 24, 3:00:17 PM GMT-5 · USD · NASDAQ ·... Stock Price Forecast. The 4 analysts offering 12-month price forecasts for SilverBow Resources Inc have a median target of 55.00, with a high estimate of 67.00 and a low estimate of 50.00. The ...Next reporting date. December 19, 2023. EPS forecast (this quarter) -$0.08. Annual revenue (last year) $130.5M. Annual profit (last year) -$142.7M. Net profit margin.ALEC Stock 12 Months Forecast. $13.78. (169.14% Upside) Based on 9 Wall Street analysts offering 12 month price targets for Alector in the last 3 months. The average price target is $13.78 with a high forecast of $41.00 and a low forecast of $4.00. The average price target represents a 169.14% change from the last price of $5.12.Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Atreca Inc have a median target of 1.50, with a high estimate of 9.00 and a low estimate of 1.00. The median estimate represents a +500.00% increase from the last price of 0.25.231.40. -1.20%. 108.31K. Find the latest Atreca Inc (BCEL) stock forecast, 12-month price target, predictions and analyst recommendations.According to the issued ratings of 9 analysts in the last year, the consensus rating for Hudbay Minerals stock is Moderate Buy based on the current 2 hold ratings and 7 buy ratings for HBM. The average twelve-month price prediction for Hudbay Minerals is C$9.18 with a high price target of C$10.50 and a low price target of C$8.00.Atreca (BCEL) suspends the development of only pipeline candidate, ATRC-101, in clinical evaluation, as part of its business restructuring efforts and cuts headcount by 40%. The stock falls 37%.

Price target. 3.25 0.00 0.00%. The 4 analysts offering 1 year price forecasts for BCEL have a max estimate of — and a min estimate of —. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cheniere Energy share forecasts, stock quote and buy / sell signals below. According to present data Cheniere Energy's LNG shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). The current Atreca [ BCEL] share price is $0.21. The Score for BCEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. BCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.Li Auto Inc - ADR Stock Forecast, LI stock price prediction. Price target in 14 days: 44.695 USD. The best long-term & short-term Li Auto Inc - ADR share price ...Instagram:https://instagram. energy spdrlabd etfstartengine phone numberlqdw dividend According to the issued ratings of 5 analysts in the last year, the consensus rating for Atreca stock is Hold based on the current 4 hold ratings and 1 buy rating for … heating oil market pricetesla y inventory Atreca, Inc. (BCEL.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Atreca, Inc. | Nasdaq: BCEL | Nasdaq lly stock price target Atreca Inc (BCEL) Stock Price & News - Google Finance Home BCEL • NASDAQ Atreca Inc Follow Share $0.21 After Hours: $0.22 (2.90%) +0.0062 Closed: Nov 24, 3:00:17 PM GMT-5 · USD · NASDAQ ·...Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Nu Holdings Ltd have a median target of 9.75, with a high estimate of 16.00 and a low estimate of 6.00. The median ...